Expanded Usage of Paxlovid Could Reduce Hospitalizations, Mortality, and Expenses

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The Univer

Related Keywords

Texas ,United States ,China ,Kobe ,Hyogo ,Japan ,Lin Wang ,Hainan ,University Of Hong Kong ,Hong Kong General ,Hong Kong ,Cambridge ,Cambridgeshire ,United Kingdom ,Alisonp Galvani ,Benjaminj Cowling ,Lauren Ancel Meyers ,Robertm Krug ,Petter Holme ,Erichy Lau ,Isaac Chun Hai Fung ,National Institutes Of Health ,Health Bureau ,University Of Cambridge ,Kobe University ,Aalto University ,Georgia Southern University ,University Of Texas At Austin ,Yale School Of Public Health ,National Natural Science Foundation Of China ,Centers For Disease ,Us National Institutes Of Health ,Research Fund ,Ut Department Of Molecular Biosciences ,Emerging Infectious ,Pandemic Decision Science ,Yale School ,Public Health ,Molecular Biosciences ,Technology Commission ,Special Administrative Region ,Disease Control ,Medical Research Fund ,National Natural Science Foundation ,